about
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing...
Read More
18.79
-0.46
(-2.39%)
885.9K
XNAS Volume
XNAS 12 Sep, 2025 4:06 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
UroGen Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..